Bahrain vs Latvia: Cause of death, by non-communicable diseases, ages 60+, male
Bahrain
80.5%
in 2021
Latvia
81.6%
in 2021
Bahrain rank
38th
Latvia rank
35th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Bahrain
- Latvia
How they compare
Latvia currently reports 81.6% against 80.5% in Bahrain, a difference of 1.1%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Bahrain ahead.
Bahrain ranks 38th and Latvia ranks 35th of 185 countries.
Across the 3 decades both report, Bahrain averaged higher in 1 and Latvia in 2.
Head to head by decade
| Decade | Bahrain | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.8% | 91.8% | 0.9% | Bahrain |
| 2010s | 93.7% | 94.0% | 0.3% | Latvia |
| 2020s | 83.1% | 86.4% | 3.2% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Bahrain or Latvia?
- Latvia, at 81.6% against 80.5% in Bahrain as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Bahrain and Latvia?
- 1.1%, with Latvia ahead.
- How many years of comparable data are there for Bahrain and Latvia?
- 6 years are reported by both, from 2000 to 2021.
- How do Bahrain and Latvia rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Bahrain ranks 38th and Latvia ranks 35th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.